RHÃN-KLINIKUM AG 18.06.2012 17:15 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification according to section 26 para. 1 WpHG Morgan Stanley & Co International Plc, London, UK, Morgan Stanley UK Group, London, UK, Morgan Stanley Group (Europe), London, UK, Morgan Stanley International Limited, London, UK, Morgan Stanley International Holdings Inc, Delaware, USA, and Morgan Stanley, Delaware, USA notified us pursuant to section 25 WpHG of the following: 1) On 11 June 2012, Morgan Stanley & Co International Plc exceeded the threshold of 5% of the voting rights of RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley & Co International Plc held 5.18% of the voting rights in RHÃN-KLINIKUM AG (equals 7,161,101 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.24% (equals 1,711,387 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.06% (equals 85,500 voting rights) is held indirectly (chain of controlled undertakings: Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender's discretion. 2) On 11 June 2012, Morgan Stanley UK Group exceeded the threshold of 5% of the voting rights of RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley UK Group held 5.18% of the voting rights in RHÃN-KLINIKUM AG (equals 7,161,101 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.24% (equals 1,711,387 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 1.24% (equals 1,711,387 voting rights) is held indirectly (chain of controlled undertakings: Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender's discretion. 3) On 11 June 2012, Morgan Stanley Group (Europe) exceeded the threshold of 5% of the voting rights of RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley Group (Europe) held 5.18% of the voting rights in RHÃN-KLINIKUM AG (equals 7,161,101 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.24% equals 1,711,387 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 1.24% (equals 1,711,387 voting rights) is held indirectly (chain of controlled undertakings: Morgan Stanley UK Group; Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender's discretion. 4) On 11 June 2012, Morgan Stanley International Limited exceeded the threshold of 5% of the voting rights of RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley International Limited held 5.18% of the voting rights in RHÃN-KLINIKUM AG (equals 7,161,101 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.24% (equals 1,711,387 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 1.24% (equals 1,711,387 voting rights) is held indirectly (chain of controlled undertakings: Morgan Stanley Group (Europe); Morgan Stanley UK Group; Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender's discretion. 5) On 11 June 2012, Morgan Stanley International Holdings Inc exceeded the threshold of 5% of the voting rights of RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley International Holdings Inc held 5.25% of the voting rights in RHÃN-KLINIKUM AG (equals 7,260,722 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.31% (equals 1,811,008 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 1.31% (equals 1,811,008 voting rights) is held indirectly (chain of controlled undertakings: MS Equity Financing Services (Luxembourg) S.a.r.l; Morgan Stanley International Limited; Morgan Stanley Group (Europe); Morgan Stanley UK Group; Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender's discretion. 6) On 11 June 2012, Morgan Stanley exceeded the threshold of 5% of the voting rights of RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley held 6.24% of the voting rights in RHÃN-KLINIKUM AG (equals 8,621,399 voting rights). From these voting rights a proportion of 4.03% (equals 5,568,769 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 2.21% (equals 3,052,630 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 2.21% (equals 3,052,630 voting rights) is held indirectly (chain of controlled undertakings: MSDW Offshore Equity Services Inc; Fundlogic SAS; Morgan Stanley Capital Management LLC; Morgan Stanley Domestic Holdings Inc; Morgan Stanley & Co LLC; MS Equity Finance Services I (Cayman) Ltd; MS Equity Financing Services (Luxembourg) S.a.r.l; Morgan Stanley International Holdings Inc; Morgan Stanley International Limited; Morgan Stanley Group (Europe); Morgan Stanley UK Group; Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender's discretion. Bad Neustadt a.d. Saale, 18 June 2012 The Board of Management ________________________________________________________________ Dr. Kai G. Klinger Head of Investor Relations RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 18.06.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: RHÃN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG